학술논문
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients.
Document Type
Letter
Author
Source
Subject
*CHRONIC myeloid leukemia
*LETTERS to the editor
*
Language
ISSN
0887-6924
Abstract
Presents a letter to the editor in response to the article "Imatinib Dose Increase Up to 1200 mg Daily Can Induce New Durable Complete Cytogenetic Remissions in Relapsed Ph+ Chronic Myeloid Leukemia Patients," published in previous issue.